Citations

Mayo Clinic

Showing 10 of 108522 citations.

Vasopressin Receptor Antagonists, Heart Failure, and Polycystic Kidney Disease
Torres, Vicente E. , Torres, Vicente E

Annual Review of Medicine | December 10, 2014 | Volume: 66 | Issue: 1 | Pages: 195-210

10.1146/annurev-med-050913-022838 | PMID 25493947 Get It

The synthesis of nonpeptide orally bioavailable vasopressin antagonists devoid of agonistic activity (vaptans) has made possible the selective blockade of vasopressin receptor subtypes for therapeutic purposes. Vaptans acting on the vasopressin V2 receptors (aquaretics) have attracted attention as a possible therapy for heart failure and polycystic kidney disease. Despite a solid rationale and encouraging preclinical testing, aquaretics have not improved clinical outcomes in randomized clinical trials for heart failure. Additional clinical trials with select population targets, more flexible dosing schedules, and possibly a different drug type or combination (balanced V1a/V2 receptor antagonism) may be warranted. Aquaretics are promising for the treatment of autosomal dominant polycystic kidney disease and have been approved in Japan for this indication. More studies are needed to better define their long-term safety and efficacy and optimize their utilization.
Equal Performance of Self-Collected and Health Care Worker-Collected Pharyngeal Swabs for Group A Streptococcus Testing by PCR
Murray, Martha A. , Schulz, Lorie A., Furst, Joseph W. , Homme, Jason H. , Jenkins, Sarah M. , Uhl, James R., Patel, Robin , Cockerill, Franklin C., Myers, Jane F., Pritt, Bobbi S. , Patel, Robin , Pritt, Bobbi S

Journal of Clinical Microbiology | December 10, 2014 | Volume: 53 | Issue: 2 | Pages: 573-578

10.1128/jcm.02500-14 | PMID 25502528 Get It

ABSTRACT A process employing patient- or parent-collected pharyngeal swabs for group A Streptococcus (GAS) testing would expedite diagnosis and treatment, reduce patient exposure to the health care setting, and decrease health care costs. Our aim was to determine the concordance between patient- or parent-collected (self-collected) and health care worker (HCW)-collected pharyngeal swabs for detection of GAS by PCR. From 9 October 2012 to 21 March 2013, patients presenting with a sore throat meeting criteria for GAS testing and not meeting criteria for severe disease were offered the opportunity to collect their own pharyngeal swab. The HCW also collected a swab. Paired swabs were tested by GAS real-time PCR, allowing semiquantitative comparisons between positive results. Of the 402 participants, 206 had a swab collected by the patient and 196 a swab collected by the parent. The percent positivity results were 33.3% for HCW-collected swabs and 34.3% for self-collected swabs ( P = 0.41). The overall concordance between the two collection strategies was 94.0% (95% confidence interval [CI], 91.3 to 96.0). Twenty-four of the paired swabs had discordant results, with 10 and 14 positives detected only with the HCW- and self-collected swabs, respectively ( P = 0.41). The person collecting the swab in the self-collected arm, the order of collection, and prior swab collection training did not influence results. Among the 124 specimens that were positive by both collection methods, the amount of GAS DNA was higher in the self-collected versus the HCW-collected swabs ( P = 0.008). Self-collected pharyngeal swabs provide a reliable alternative to HCW collection for detection of GAS and offer a strategy for improved health care delivery.
Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections
Noel, Pawan, Patel, Krutika , Durgampudi, Chandra, Trivedi, Ram N., Oliveira, Cristiane de , Pannala, Rahul , Lee, Kenneth , Chennat, Jennifer, Slivka, Adam, Khalid, Asif , DeLany, James P. , Cline, Rachel, Acharya, Chathur , Jaligama, Deepthi, Murad, Faris, Yadav, Dhiraj , Navina, Sarah, Singh, Vijay , de Oliveira, Cristiane, Singh, Vijay P, Crowell, Michael D. , Brand, Randall E. , Papachristou, Georgios I. , Whitcomb, David C. , Singh, Vijay P

Gut | December 10, 2014 | Volume: 65 | Issue: 1 | Pages: 100-111

10.1136/gutjnl-2014-308043 | PMID 25500204 Get It

Background and aims Peripancreatic fat necrosis occurs frequently in necrotising pancreatitis. Distinguishing markers from mediators of severe acute pancreatitis (SAP) is important since targeting mediators may improve outcomes. We evaluated potential agents in human pancreatic necrotic collections (NCs), pseudocysts (PCs) and pancreatic cystic neoplasms and used pancreatic acini, peripheral blood mononuclear cells (PBMC) and an acute pancreatitis (AP) model to determine SAP mediators. Methods We measured acinar and PBMC injury induced by agents increased in NCs and PCs. Outcomes of caerulein pancreatitis were studied in lean rats coadministered interleukin (IL)-1β and keratinocyte chemoattractant/growth-regulated oncogene, triolein alone or with the lipase inhibitor orlistat. Results NCs had higher fatty acids, IL-8 and IL-1β versus other fluids. Lipolysis of unsaturated triglyceride and resulting unsaturated fatty acids (UFA) oleic and linoleic acids induced necro-apoptosis at less than half the concentration in NCs but other agents did not do so at more than two times these concentrations. Cytokine coadministration resulted in higher pancreatic and lung inflammation than caerulein alone, but only triolein coadministration caused peripancreatic fat stranding, higher cytokines, UFAs, multisystem organ failure (MSOF) and mortality in 97% animals, which were prevented by orlistat. Conclusions UFAs, IL-1β and IL-8 are elevated in NCs. However, UFAs generated via peripancreatic fat lipolysis causes worse inflammation and MSOF, converting mild AP to SAP.
The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
Parmar, Priya , Krishnamurthi, Rita , Ikram, M. Arfan , Hofman, Albert , Mirza, Saira Saeed , Varakin, Yury, Kravchenko, Michael , Пирадов, М. А. , Thrift, Amanda G. , Wang, Wenzhi , Mandal, Dipes Kumar , Barker‐Collo, Suzanne , Sahathevan, Ramesh , Saposnik, Gustavo , Sindi, Shireen , Bornstein, Natan M. , Giroud, Maurice , Béjot, Yannick , Brainin, Michael , Narayan, K M Venkat, Correia, Manuel , Kokubo, Yoshihiro , Wiebers, David O. , BinDhim, Nasser F. , Barber, P. Alan , Pandian, Jeyaraj , Hankey, Graeme J. , Mehndiratta, Man Mohan , Azhagammal, Shobhana, Ibrahim, Norlinah Mohd, Abbott, Max , Hume, Patria , Hussein, Tasleem, Bhattacharjee, Rohit, Purohit, Mitali, Feigin, Valery L. , Narayan, K.M. Venkat , Mirza, Saira Saeed , Varakin, Yu. Ya., Norrving, Bo , Davis, Stephen M. , Kivipelto, Miia , Poulton, Richie , Freire, Antônio Fernando Menezes , Mensah, George A. , Rush, Elaine Carolyn , Hankey, Graeme J , Pandian, Jeyaraj , Kravchenko, Michael , Thrift, Amanda , Ibrahim, Norlinah Mohamed

International Journal of Stroke | December 10, 2014 | Volume: 10 | Issue: 2 | Pages: 231-244

10.1111/ijs.12411 | PMID 25491651 Get It

Background The greatest potential to reduce the burden of stroke is by primary prevention of first-ever stroke, which constitutes three quarters of all stroke. In addition to population-wide prevention strategies (the ‘mass’ approach), the ‘high risk’ approach aims to identify individuals at risk of stroke and to modify their risk factors, and risk, accordingly. Current methods of assessing and modifying stroke risk are difficult to access and implement by the general population, amongst whom most future strokes will arise. To help reduce the burden of stroke on individuals and the population a new app, the Stroke Riskometer™, has been developed. We aim to explore the validity of the app for predicting the risk of stroke compared with current best methods. Methods 752 stroke outcomes from a sample of 9501 individuals across three countries (New Zealand, Russia and the Netherlands) were utilized to investigate the performance of a novel stroke risk prediction tool algorithm (Stroke Riskometer™) compared with two established stroke risk score prediction algorithms (Framingham Stroke Risk Score [FSRS] and QStroke). We calculated the receiver operating characteristics (ROC) curves and area under the ROC curve (AUROC) with 95% confidence intervals, Harrels C-statistic and D-statistics for measure of discrimination, R2 statistics to indicate level of variability accounted for by each prediction algorithm, the Hosmer-Lemeshow statistic for calibration, and the sensitivity and specificity of each algorithm. Results The Stroke Riskometer™ performed well against the FSRS five-year AUROC for both males (FSRS = 75·0% (95% CI 72·3%–77·6%), Stroke Riskometer™ = 74·0(95% CI 71·3%–76·7%) and females [FSRS = 70·3% (95% CI 67·9%–72·8%, Stroke Riskometer™ = 71·5% (95% CI 69·0%–73·9%)], and better than QStroke [males–59·7% (95% CI 57·3%–62·0%) and comparable to females = 71·1% (95% CI 69·0%–73·1%)]. Discriminative ability of all algorithms was low (C-statistic ranging from 0·51–0·56, D-statistic ranging from 0·01–0·12). Hosmer-Lemeshow illustrated that all of the predicted risk scores were not well calibrated with the observed event data ( P < 0·006). Conclusions The Stroke Riskometer™ is comparable in performance for stroke prediction with FSRS and QStroke. All three algorithms performed equally poorly in predicting stroke events. The Stroke Riskometer™ will be continually developed and validated to address the need to improve the current stroke risk scoring systems to more accurately predict stroke, particularly by identifying robust ethnic/race ethnicity group and country specific risk factors.
Perinatal oxygen in the developing lung
Vogel, Elizabeth R. , Britt, Rodney D. , Trinidad, Mari Charisse, Faksh, Arij , Martin, Richard J. , MacFarlane, Peter M. , Prakash, Y. S. , Pabelick, Christina M. , Prakash, Y S , Vogel, Elizabeth R

Canadian Journal of Physiology and Pharmacology | December 9, 2014 | Volume: 93 | Issue: 2 | Pages: 119-127

10.1139/cjpp-2014-0387 | PMID 25594569 Get It

Lung diseases, such as bronchopulmonary dysplasia (BPD), wheezing, and asthma, remain significant causes of morbidity and mortality in the pediatric population, particularly in the setting of premature birth. Pulmonary outcomes in these infants are highly influenced by perinatal exposures including prenatal inflammation, postnatal intensive care unit interventions, and environmental agents. Here, there is strong evidence that perinatal supplemental oxygen administration has significant effects on pulmonary development and health. This is of particular importance in the preterm lung, where premature exposure to room air represents a hyperoxic insult that may cause harm to a lung primed to develop in a hypoxic environment. Preterm infants are also subject to increased episodes of hypoxia, which may also result in pulmonary damage and disease. Here, we summarize the current understanding of the effects of oxygen on the developing lung and how low vs. high oxygen may predispose to pulmonary disease that may extend even into adulthood. Better understanding of the underlying mechanisms will help lead to improved care and outcomes in this vulnerable population.
Acute‐phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis
Thaler, Roman , Sturmlechner, Ines , Spitzer, Silvia , Riester, Scott M. , Rumpler, M., Zwerina, Jochen , Klaushofer, Klaus, Wijnen, André J. van , Varga, Franz, Rumpler, Monika, van Wijnen, Andre J, van Wijnen, Andre J , Sturmlechner, Ines

The FASEB Journal | December 9, 2014 | Volume: 29 | Issue: 4 | Pages: 1344-1359

10.1096/fj.14-265512 | PMID 25491310 Get It

Serum amyloid A (A‐SAA/Saa3) was shown before to affect osteoblastic metabolism. Here, using RT‐quantitative PCR and/or immunoblotting, we show that expression of mouse Saa3 and human SAA1 and SAA2 positively correlates with increased cellular maturation toward the osteocyte phenotype. Expression is not detected in C3H10T1/2 embryonic fibroblasts but is successively higher in preosteoblastic MC3T3‐E1 cells, late osteoblastic MLO‐A5 cells, and MLO‐Y4 osteocytes, consistent with findings using primary bone cells from newborn mouse calvaria. Recombinant Saa3 protein functionally inhibits osteoblast differentiation as reflected by reductions in the expression of osteoblast markers and decreased mineralization in newborn mouse calvaria. Yet, Saa3 protein enhances osteoclastogenesis in mouse macrophages/monocytes based on the number of multinucleated and tartrate‐resistant alkaline phosphatase‐positive cells and Calcr mRNA expression. Depletion of Saa3 in MLO osteocytes results in the loss of the mature osteocyte phenotype. Recombinant osteocalcin, which is reciprocally regulated with Saa3 at the osteoblast/osteocyte transition, attenuates Saa3 expression in MLO‐Y4 osteocytes. Mechanistically, Saa3 produced by MLO‐Y4 osteocytes is integrated into the extracellular matrix of MC3T3‐E1 osteoblasts, where it associates with the P2 purinergic receptor P2rx7 to stimulate Mmp13 expression via the P2rx7/MAPK/ERK/activator protein 1 axis. Our data suggest that Saa3 may function as an important coupling factor in bone development and homeostasis.—Thaler, R., Sturmlechner, I., Spitzer, S., Riester, S. M., Rumpler, M., Zwerina, J., Klaushofer, K., vanWijnen, A. J., Varga, F. Acute‐phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis. FASEB J. 29, 1344‐1359 (2015). www.fasebj.org
Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma
Brown, Lindsay C. , Lester, Rachael, Haddock, Michael G. , Olivier, Kenneth R. , Arndt, Carola A.S., Rose, Peter S. , Lester, Rachael A, Grams, Michael P. , Laack, Nadia N.

Sarcoma | December 9, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-9

10.1155/2014/418270 | PMID 25548538 Get It

Background. Radiotherapy has been utilized for metastatic and recurrent osteosarcoma and Ewing sarcoma (ES), in order to provide palliation and possibly prolong overall or progression-free survival. Stereotactic body radiotherapy (SBRT) is convenient for patients and offers the possibility of increased efficacy. We report our early institutional experience using SBRT for recurrent and metastatic osteosarcoma and Ewing sarcoma.Methods. We reviewed all cases of osteosarcoma or ES treated with SBRT between 2008 and 2012.Results. We identified 14 patients with a total of 27 lesions from osteosarcoma(n=19)or ES(n=8). The median total curative/definitive SBRT dose delivered was 40 Gy in 5 fractions (range, 30–60 Gy in 3–10 fractions). The median total palliative SBRT dose delivered was 40 Gy in 5 fractions (range, 16–50 Gy in 1–10 fractions). Two grade 2 and 1 grade 3 late toxicities occurred, consisting of myonecrosis, avascular necrosis with pathologic fracture, and sacral plexopathy. Toxicity was seen in the settings of concurrent chemotherapy and reirradiation.Conclusions. This descriptive report suggests that SBRT may be a feasible local treatment option for patients with osteosarcoma and ES. However, significant toxicity can result, and thus systematic study is warranted to clarify efficacy and characterize long-term toxicity.
Colonoscopy in liver disease
Ratuapli, Shiva K., Vargas, Hugo E. , Vargas, Hugo E

Clinical Liver Disease | December 9, 2014 | Volume: 4 | Issue: 5 | Pages: 109-112

10.1002/cld.433 | PMID 30992934 Get It

Therapeutic phlebotomy
Zubair, Abba C. , Zubair, Abba

Clinical Liver Disease | December 9, 2014 | Volume: 4 | Issue: 5 | Pages: 102-106

10.1002/cld.408 | PMID 30992932 Get It

Comment on: The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma—implications on the T‐classification system
Jambusaria‐Pahlajani, Anokhi , Parker, Alexander S. , Schmults, Chrysalyne D. , Karia, Pritesh S.

Journal of Surgical Oncology | December 9, 2014 | Volume: 111 | Issue: 4 | Pages: 483-484

10.1002/jso.23841 | PMID 25492622 Get It